Doctor says Avandia maker threatened to sue when he raised safety questions

WASHINGTON (AP) - The controversy surrounding GlaxoSmithKline's diabetes drug Avandia grew Wednesday as a medical expert told the U.S. Congress that executives threatened to sue when he first raised questions in 1999 about the treatment's safety....More